Interferon-γ: Interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue

Journal of Rheumatology

Volumn 29, Issue 2, 2002, Pages 369-378

  Scola, Michael P ^a   Thompson, Susan D ^a   Brunner, Hermine I ^a   Tsoras, Monica K ^a   Witte, David ^a   Van Dijk, Marc A ^a   Grom, Alexei A ^a   Passo, Murray H ^a   Glass, David N ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Interferon ; Interleukin 12; Interleukin 15; Interleukin 18; Juvenile rheumatoid arthritis; Synovial tissue

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; JUVENILE RHEUMATOID ARTHRITIS; MALE; PRIORITY JOURNAL; SYNOVIUM; TISSUE DISTRIBUTION;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-18; INTERLEUKIN-4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 0036163273     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis
2. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
3. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis
4. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent
5. Human CD4+ T cell differentiation and effector function: Implications for autoimmunity
6. Identification of Th subsets in juvenile rheumatoid arthritis confirmed by intracellular cytokine staining
7. Cytokine production by synovial T cells in rheumatoid arthritis
8. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: Prominence of interleukin 4 in restricted disease
9. Islet-specific Thl, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes
10. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease
11. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4
12. Significance of low mRNA levels of interleukin-4 and -10 in mononuclear cells of the synovial fluid of patients with rheumatoid arthritis
13. Juvenile rheumatoid arthritis and the trimolecular complex (HLA, T cell receptor, and antigen). Differences from rheumatoid arthritis
14. Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis
15. T cell-derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells
16. IL-12 unmasks latent autoimmune disease in resistant mice
17. IL-12 in autoimmunity
18. Complement and IL-12: Yin and yang
19. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice
20. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
21. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
22. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
23. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
24. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro
25. Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo
26. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
27. A proinflammatory role for IL-18 in rheumatoid arthritis
28. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme
29. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
30. Reduced expression of a human V beta 6.1 T-cell receptor allele
31. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis
32. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
33. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses
34. Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease
35. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis
36. Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: Evidence for antigenic selection of T cells in the synovium
37. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis
38. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype
39. IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation
40. The role of interleukin-10 (IL-10) in IL-15-mediated T-cell responses
41. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells
42. High-dose IL-2 and IL-15 enhance the in vitro priming of naive CD4+ T cells for IFN-gamma but have differential effects on priming for IL-4
43. Autocrine and paracrine regulation of human T cell IL-10 production
44. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis
45. Expression of angiogenic factors in juvenile rheumatoid arthritis: Correlation with revascularization of human synovium engrafted into SCID mice
46. Interleukin-15 promotes angiogenesis in vivo
47. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15
48. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis
49. CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes
50. Interleukin-15 protects from lethal apoptosis in vivo
51. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis
52. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes
53. IFN-gamma and 1,25(OH)2D3 induce on THP- 1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells
54. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response
55. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis
56. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis
57. Etanercept in children with polyarticular juvenile rheumatoid arthritis